What Happened?

Shares of personal care company Nu Skin (NYSE:NUS) jumped 13.3% in the morning session after the company reported strong preliminary Q4 2024 guidance, with revenue expected to be at the high end of the previous guidance range. A day after this report, the company is expected to share updates on its strategy, including the recent sale of Mavely for $250 million. Overall, the updates provide more reasons for investors to stay optimistic.

Is now the time to buy Nu Skin? Access our full analysis report here, it’s free.

What The Market Is Telling Us

Nu Skin’s shares are very volatile and have had 22 moves greater than 5% over the last year. But moves this big are rare even for Nu Skin and indicate this news significantly impacted the market’s perception of the business. 

The previous big move we wrote about was 10 days ago when the stock gained 21.9% on the news that the company announced the sale of the Mavely affiliate technology platform, owned by its subsidiary Rhyz Inc., to Later, a marketing and social media management software firm. Valued at $250 million, the deal delivered a substantial payoff, with management adding, "This transaction yielded roughly a fivefold return on the company's total investment in Mavely since its acquisition in 2021."

Nu Skin is up 3.5% since the beginning of the year, but at $6.79 per share, it is still trading 64.2% below its 52-week high of $18.96 from January 2024. Investors who bought $1,000 worth of Nu Skin’s shares 5 years ago would now be looking at an investment worth $166.46.

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.